Magnetic Resonance Elastography in Liver Disease Assessment

Magnetic resonance elastography (MRE) is an advanced imaging technique that non-invasively quantifies the mechanical properties of liver tissue by inducing low-frequency shear waves and detecting their propagation with MRI. By mapping tissue stiffness and viscoelastic parameters, MRE enables accurate staging of hepatic fibrosis, detection of inflammatory activity, evaluation of portal hypertension and assessment of functional reserve. This technique addresses limitations of serum biomarkers and ultrasound-based elastography by providing full-field-of-view elastograms, high reproducibility across centres and robustness in obese or ascitic patients. Clinically, MRE guides treatment decisions in chronic viral hepatitis, non-alcoholic fatty liver disease (NAFLD) and cirrhosis, monitors response to antiviral or antifibrotic therapies and may predict complications such as variceal development. Ongoing refinements, including multifrequency acquisition and tomoelastography, aim to disentangle fibrosis from inflammation and to shorten scan times, thereby enhancing the role of MRE in routine hepatology practice worldwide.

Research from Nature Portfolio

Recent studies have demonstrated that MRE retains high diagnostic accuracy in populations traditionally considered challenging. In overweight and obese patients with non-alcoholic fatty liver disease, magnetic resonance elastography and vibration-controlled transient elastography achieved comparable performance in detecting moderate to advanced fibrosis, while MRI-derived proton density fat fraction outperformed ultrasound-based steatosis measurements across all body-mass index categories. In a prospective cohort of chronic hepatitis C and non-alcoholic fatty liver disease, shear wave elastography, transient elastography, serum fibrosis indices and MRE showed strong inter-technique correlations at baseline and at one-year follow-up, with MRE serving as a stable reference standard. These findings underscore the versatility of MRE in diverse clinical settings and support its integration with other non-invasive tests for comprehensive liver assessment.

Magnetic Resonance Elastography in Liver Disease Assessment publication trend

The graph below shows the total number of articles in magnetic resonance elastography in liver disease assessment across all publications each year (not limited to Nature Index journals).

Technical terms

Magnetic Resonance Elastography (MRE): A non-invasive MRI-based technique that measures tissue stiffness by generating and imaging the propagation of mechanical shear waves.

Viscoelasticity: The combined viscous and elastic response of biological tissues to mechanical stress, manifesting as both energy storage and dissipation.

Shear wave speed: The velocity at which mechanical shear waves travel through tissue, directly related to tissue stiffness and often expressed in metres per second (m/s).

Proton density fat fraction (PDFF): A quantitative MRI biomarker that measures the proportion of fat protons within liver tissue, used to assess hepatic steatosis.

References

1. On the relationship between metabolic capacities and in vivo viscoelastic properties of the liver. Frontiers in Bioengineering and Biotechnology (2023).
2. Viscoelastic parameters derived from multifrequency MR elastography for depicting hepatic fibrosis and inflammation in chronic viral hepatitis. Insights into Imaging (2024).
3. Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy. PLOS ONE (2012).
4. Diagnostic performance of tomoelastography of the liver and spleen for staging hepatic fibrosis. European Radiology (2019).
5. Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease. BioMed Research International (2017).
6. Magnetic resonance elastography in staging liver fibrosis in non-alcoholic fatty liver disease: a pooled analysis of the diagnostic accuracy. BMC Gastroenterology (2020).
7. MR elastography in nonalcoholic fatty liver disease: inter-center and inter-analysis-method measurement reproducibility and accuracy at 3T. European Radiology (2021).
8. Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD. Scientific Reports (2022).
9. Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study. Scientific Reports (2022).